Systemic mastocytosis with associated hematologic neoplasm (SM-AHN) presents unique diagnostic and treatment challenges. In this Medscape-certified activity, experts discuss the complex patient journey, from delayed diagnosis to individualized…
Avapritinib, branded as Ayvakit, became the first FDA-approved treatment for indolent systemic mastocytosis (ISM) in 2023, marking a major advancement for patients. ISM, driven by the KIT D816V…
What are the latest treatment options for patients with #AML? @manosnikolousis discusses treatment options with a clinical nurse specialist and a patient with AML.
Part 1 – Case Presentation & Debate Setup D. Ross Camidge, MD, PhD, and Erin Schenk, MD, PhD, medical oncologists at the University of Colorado Cancer Center, discuss…
Part 2 – Case Discussion & Debate D. Ross Camidge, MD, PhD, and Erin Schenk, MD, PhD, medical oncologists at the University of Colorado Cancer Center, discuss the…
Judith L. Pearson, best-selling author of The Wolves at the Door: The True Story of America’s Greatest Female Spy, recently released her latest book – From Shadows to…
Part 1 – Case Presentation Erin Schenk, MD, PhD, and D. Ross Camidge, MD, PhD, medical oncologists at the University of Colorado Cancer Center, discuss the case of…
Part 2 – Case Discussion Erin Schenk, MD, PhD, and D. Ross Camidge, MD, PhD, medical oncologists at the University of Colorado Cancer Center, discuss treatment options, including…
Part 3 – Case Discussion & Wrap-up Erin Schenk, MD, PhD, and D. Ross Camidge, MD, PhD, medical oncologists at the University of Colorado Cancer Center, continue to…
